NCT02464696: Early Non Invasive Ventilation and Hematological Malignancies

NCT02464696
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: 
Exclusions: Patients with metastatic malignancy in the lungs or pleural space that cause respiratory insufficiency
https://ClinicalTrials.gov/show/NCT02464696

Comments are closed.

Up ↑